Tanya Jewell
Pfizer (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Biochemical and Molecular Research, Computational Drug Discovery Methods, Hepatitis B Virus Studies
Most-Cited Works
- → Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor(2009)119 cited
- → Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors(2006)54 cited
- → Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide(2011)42 cited
- → Allosteric Inhibitors of Hepatitis C Polymerase: Discovery of Potent and Orally Bioavailable Carbon-Linked Dihydropyrones(2007)33 cited
- → Preparation of immobilized swainsonine analogs on solid support(2002)10 cited
- → Synthetic Route Optimization of PF-00868554, An HCV Polymerase Inhibitor in Clinical Evaluation(2010)1 cited